Pfizer Completes Acquisition of Metsera
Metsera Inc MTSR
News
Metsera Shares Fall Premarket as Novo Throws in Towel on Bidding War
Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.
Novo Nordisk Shares Rise After Withdrawal of Metsera Takeover Battle
Pfizer is losing its fight with Novo Nordisk to get back in the obesity-drug game
Pfizer Files Second Lawsuit Seeking to Block Novo Nordisk's Bid for Metsera
Novo Nordisk Seeks to Outmuscle Pfizer With Up to $9 Billion Bid for Metsera — 2nd Update
Novo Nordisk Seeks to Muscle Out Pfizer With Up to $9 Billion Bid for Metsera — Update
Metsera Shares Leap Premarket as Novo Nordisk Looks to Outbid Pfizer
Novo Nordisk Moves to Outbid Pfizer With Up to $9 Billion Offer for Obesity Drug Developer Metsera
Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion — 2nd Update
Pfizer makes a $4.9 billion bet on obesity drugs with Metsera buyout deal
Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion — Update
Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion
Metsera Shares Leap Premarket on Report of Takeover by Pfizer
Pfizer Nears $7.3 Billion Metsera Deal, FT Says, Citing Sources
United States